Confirmation of Putative HIV-1 Group P in Cameroon

被引：89
|
作者：
Vallari, Ana
Holzmayer, Vera
Harris, Barbara
Yamaguchi, Julie
Ngansop, Charlotte [2 ]
Makamche, Florence [2 ]
Mbanya, Dora [2 ]
Kaptue, Lazare [2 ,3 ]
Ndembi, Nicaise [2 ,4 ]
Guertler, Lutz [5 ]
Devare, Sushil
Brennan, Catherine A. [1 ]
机构：
[1] Abbott Diagnost, Dept 09NG, Abbott Pk, IL 60064 USA
[2] Univ Yaounde 1, Yaounde, Cameroon
[3] Univ Montagnes, Bangangte, Cameroon
[4] Inst Human Virol, Abuja, Nigeria
[5] Univ Munich, Max Von Pettenkofer Inst, Munich, Germany
来源：
JOURNAL OF VIROLOGY | 2011年 / 85卷 / 03期
关键词：
IMMUNODEFICIENCY VIRUSES; GROUP-O; GROUP N; IDENTIFICATION; PREVALENCE; GORILLAS;
D O I：
10.1128/JVI.02005-10
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
We report the second human immunodeficiency virus (HIV) belonging to the new HIV type 1 (HIV-1) group P lineage that is closely related to the simian immunodeficiency virus found in gorillas. This virus was identified in an HIV-seropositive male hospital patient in Cameroon, confirming that the group P virus is circulating in humans. Results from screening 1,736 HIV-seropositive specimens collected in Cameroon indicate that HIV-1 group P infections are rare, accounting for only 0.06% of HIV infections. Despite its rarity, group P shows evidence of adaptation to humans.
引用
收藏
页码：1403 / 1407
页数：5
相关论文
共 50 条
  • [41] HIV plasma RNA for confirmation of HIV-1 p24Ag/anti-HIV reactivity in seroconverting (SC) donors.
    Busch, MP
    Satten, GA
    Herman, SA
    Sakahara, NS
    Garrett, PE
    Stramer, SL
    Schumacher, R
    TRANSFUSION, 1996, 36 (09) : S163 - S163
  • [42] EVALUATION OF A LINE IMMUNOASSAY FOR SIMULTANEOUS CONFIRMATION OF ANTIBODIES TO HIV-1 AND HIV-2
    FRANSEN, K
    POLLET, DE
    PEETERS, M
    VANKERCKHOVEN, I
    BEELAERT, G
    VERCAUTEREN, G
    PIOT, P
    VANDERGROEN, G
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (11) : 939 - 946
  • [43] Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon
    Faria, Nuno R.
    Suchard, Marc A.
    Abecasis, Ana
    Sousa, Joao D.
    Ndembi, Nicaise
    Bonfim, Idalina
    Camacho, Ricardo J.
    Vandamme, Anne-Mieke
    Lemey, Philippe
    INFECTION GENETICS AND EVOLUTION, 2012, 12 (02) : 453 - 460
  • [44] Prevalence of HIV-1 drug resistance in HIV-1-infected patients treated in Douala, Cameroon
    Charpentier, C.
    Talla, F.
    Joko, A.
    Si-Mohamed, A.
    Belec, L.
    ANTIVIRAL THERAPY, 2009, 14 (04) : A191 - A191
  • [45] Immunofluorescence assay in India for confirmation of HIV-1 infection using a T-cell line infected with defective HIV-1
    Bala, Manju
    Arias, Juan F.
    Deb, Monorama
    Ikuta, Kazuyoshi
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 (12) : E1093 - E1098
  • [46] HIV infections in Northwestern Cameroon: Identification of HIV type 1 group O and dual HIV type 1 group M and group O infections
    Yamaguchi, J
    Bodelle, P
    Vallari, AS
    Coffey, R
    McArthur, CP
    Schochetman, G
    Devare, SG
    Brennan, CA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2004, 20 (09) : 944 - 957
  • [47] Scientists identify a new HIV-1 group
    Morris, K
    LANCET, 1998, 352 (9130): : 791 - 791
  • [48] A new HIV-1 group - Abstract and commentary
    Delwart, E
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (22): : 1960 - 1960
  • [49] Identification of rare HIV-1 Group N, HBV AE, and HTLV-3 strains in rural South Cameroon
    Rodgers, M. A.
    Vallari, A. S.
    Harris, B.
    Yamaguchi, J.
    Holzmayer, V.
    Forberg, K.
    Berg, M. G.
    Kenmenge, J.
    Ngansop, C.
    Awazi, B.
    Mbanya, D.
    Kaptue, L.
    Brennan, C.
    Cloherty, G.
    Ndembi, N.
    VIROLOGY, 2017, 504 : 141 - 151
  • [50] HIV-1 group O infection in the USA
    Gould, K
    Britvan, L
    Dryjanski, J
    LANCET, 1996, 348 (9028): : 680 - 681
12345